Suppr超能文献

唐氏综合征患儿的心肺表型和蛋白质特征

Cardiopulmonary Phenotypes and Protein Signatures in Children With Down Syndrome.

作者信息

DeBoer Emily M, Wolter-Warmerdam Kristine, Deterding Robin R, Marmolejo Juana, Blumenthal Tom, Espinosa Joaquin M, Hickey Francis, Wagner Brandie D

机构信息

Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.

Children's Hospital Colorado, Aurora, CO, USA.

出版信息

Clin Pediatr (Phila). 2024 May;63(4):474-481. doi: 10.1177/00099228231179453. Epub 2023 Jun 12.

Abstract

Pulmonary disease, lower respiratory tract infection, and pneumonia are the largest causes of morbidity and mortality in individuals with Down syndrome (DS), but whether pulmonary diagnoses in children with DS are common and occur independently of cardiac disease and pulmonary hypertension (PH) is unknown. Cardiopulmonary phenotypes were examined in a cohort of 1248 children with DS. Aptamer-based proteomic analysis of blood was performed in a subset (n = 120) of these children. By the age of 10 years, half of the patients in this cohort (n = 634, 50.8%) had co-occurring pulmonary diagnoses. That proteins and related pathways were distinct between children with pulmonary diagnoses and those with cardiac disease and/or PH may indicate that pulmonary diagnoses appear to occur independently of cardiac disease and PH. Heparin sulfate-glycosaminoglycandegradation, nicotinate metabolism, and elastic fiber formation were ranked highest in the group with pulmonary diagnoses.

摘要

肺部疾病、下呼吸道感染和肺炎是唐氏综合征(DS)患者发病和死亡的主要原因,但DS患儿的肺部诊断是否常见且独立于心脏病和肺动脉高压(PH)尚不清楚。对1248名DS患儿的队列进行了心肺表型检查。对这些患儿中的一个亚组(n = 120)进行了基于适配体的血液蛋白质组分析。到10岁时,该队列中的一半患者(n = 634,50.8%)同时患有肺部疾病诊断。肺部疾病诊断患儿与心脏病和/或PH患儿之间的蛋白质及相关通路不同,这可能表明肺部疾病诊断似乎独立于心脏病和PH而出现。硫酸乙酰肝素-糖胺聚糖降解、烟酸代谢和弹性纤维形成在肺部疾病诊断组中排名最高。

相似文献

1
Cardiopulmonary Phenotypes and Protein Signatures in Children With Down Syndrome.
Clin Pediatr (Phila). 2024 May;63(4):474-481. doi: 10.1177/00099228231179453. Epub 2023 Jun 12.
2
Pulmonary hypertension and myocardial function in infants and children with Down syndrome.
Arch Dis Child. 2020 Nov;105(11):1031-1034. doi: 10.1136/archdischild-2019-318178. Epub 2020 Mar 11.
3
Pulmonary hypertension in children with Down syndrome.
Pediatr Pulmonol. 2021 Mar;56(3):621-629. doi: 10.1002/ppul.24687. Epub 2020 Feb 12.
4
Clinical Characteristics and Risk Factors for Developing Pulmonary Hypertension in Children with Down Syndrome.
J Pediatr. 2018 Nov;202:212-219.e2. doi: 10.1016/j.jpeds.2018.06.031. Epub 2018 Jul 17.
5
6
An Analysis of Hospital Mortality After Cardiac Operations in Children With Down Syndrome.
Semin Thorac Cardiovasc Surg. 2020;32(4):947-957. doi: 10.1053/j.semtcvs.2020.06.037. Epub 2020 Jul 2.
7
Multiorgan involvement and management in children with Down syndrome.
Acta Paediatr. 2020 Jun;109(6):1096-1111. doi: 10.1111/apa.15153. Epub 2020 Jan 24.
8
Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.
BMC Cardiovasc Disord. 2017 Jul 4;17(1):177. doi: 10.1186/s12872-017-0569-3.
9
Phenotyping Down syndrome: discovery and predictive modelling with electronic medical records.
J Intellect Disabil Res. 2024 May;68(5):491-511. doi: 10.1111/jir.13124. Epub 2024 Feb 1.
10
Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry.
J Pediatr. 2023 Jan;252:131-140.e3. doi: 10.1016/j.jpeds.2022.08.027. Epub 2022 Aug 24.

本文引用的文献

1
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.
Ann Intern Med. 2021 Apr;174(4):572-576. doi: 10.7326/M20-4986. Epub 2020 Oct 21.
2
Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.
Am J Med Genet A. 2020 Dec;182(12):2964-2970. doi: 10.1002/ajmg.a.61867. Epub 2020 Sep 12.
3
4
EXPRESS: Angiogenic Profile Identifies Pulmonary Hypertension in Children with Down Syndrome.
Pulm Circ. 2019 Jul 11;9(3):2045894019866549. doi: 10.1177/2045894019866549.
5
Clinical Characteristics and Risk Factors for Developing Pulmonary Hypertension in Children with Down Syndrome.
J Pediatr. 2018 Nov;202:212-219.e2. doi: 10.1016/j.jpeds.2018.06.031. Epub 2018 Jul 17.
6
Elastin in lung development and disease pathogenesis.
Matrix Biol. 2018 Nov;73:6-20. doi: 10.1016/j.matbio.2018.01.005. Epub 2018 Jan 11.
7
Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.
Sci Rep. 2017 Nov 1;7(1):14818. doi: 10.1038/s41598-017-13858-3.
8
Proteomic profiling identifies novel circulating markers associated with bronchiectasis in cystic fibrosis.
Proteomics Clin Appl. 2017 Sep;11(9-10). doi: 10.1002/prca.201600147. Epub 2017 May 29.
9
Prominent Intrapulmonary Bronchopulmonary Anastomoses and Abnormal Lung Development in Infants and Children with Down Syndrome.
J Pediatr. 2017 Jan;180:156-162.e1. doi: 10.1016/j.jpeds.2016.08.063. Epub 2016 Sep 22.
10
Combining dependent P-values with an empirical adaptation of Brown's method.
Bioinformatics. 2016 Sep 1;32(17):i430-i436. doi: 10.1093/bioinformatics/btw438.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验